XENOGESIS LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
Discovery Building Biocity Pennyfoot Street Nottingham United Kingdom NG1 1GR Copied!

Latest financial results as of 2 September 2025
Cash in bank
£652.07k
Current assets
£857.61k
Current creditors
£123.43k
Shareholders funds
£823.19k
View full financial accounts

Company number
07541784 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Dormant
Incorporated on
24 February 2011
Accounts

Latest annual accounts were to 31 March 2024

Next annual accounts are due by 31 December 2025

Company financial year end is on 31 March 2026

Confirmation statement

Latest confirmation statement statement dated 24 February 2025

Next statement due by 10 March 2026

View original and historic source data
Nature of business (SIC)

99999 - Dormant Company

Previous company names

NameDate previous name changed
FULLY INTEGRATED PHARMA SOLUTIONS LIMITED22 June 2011

Latest company documents
DateDescription
07/03/257 March 2025 Confirmation statement made on 2025-02-24 with no updates

View Document

05/01/255 January 2025

View Document

05/01/255 January 2025 Accounts for a dormant company made up to 2024-03-31

View Document

05/01/255 January 2025

View Document

10/07/2410 July 2024 Termination of appointment of Paul Douglas Overton as a director on 2024-05-20

View Document

View all company documents
AI-Powered Analysis for XENOGESIS LIMITED

Get instant insights with Claude AI. Ask questions like:

  • "Is XENOGESIS LIMITED financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about XENOGESIS LIMITED:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company